drugset / Trial / NCT01865916

2L Oral Bi-PegLyte Versus 2L Oral MoviPrep Regimen for Outpatient Colonic Preparation

NCT01865916

Phase 4 Completed 309 enrolled University of British Columbia
RandomizedParallel-groupOpen-label

Summary

This study is a randomized, controlled, single centre, endoscopist-blinded non-inferiority trial. The purpose of our study is to determine if using a 2-litre mixture in combination with vitamin C is better than using 2 litres of mixture with bisacodyl tablets. Two-litre PegLyte based preparations with an added laxative agent are commonly used for colonoscopies in outpatient settings. If the investigators discover that a 2-litre mixture with either the tablets or the ascorbic acid work better, future patients undergoing colonoscopy will be able to experience fewer side effects and be less troubled by the preparation while still allowing a good view of the colon.

Timeline

Start
2013-04
Primary completion
2015-12
Completion
2016-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bisacodyl Small molecule 15 mg Oral
Subject Vitamin C Other / unclassified Oral
Comparator polyethylene glycol Other / unclassified 2000 ml Oral

Indications

No indication recorded.